Expecting 15% Revenue Growth in FY16: Dishman Pharma
Arpit Vyas, managing director at Dishman Pharmaceuticals and Chemicals, told NDTV that it has added 10-15 small and mid-sized biotech companies which will contribute to the revenue growth next financial year.
